Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Approvals Analysis: Hits Just Keep On Coming. Can It Last?

Executive Summary

2017 was another record year for novel device approvals in the US, with typical large numbers of cardiovascular and IVD go-aheads, along with notable successes in neurology, with noninvasive stimulation and digital-app solutions seeing success. There was also an increase in 510(k) clearances last year. Here's a look at some key FDA approvals and clearance trends from the past year, including in infographic form.

Advertisement

Related Content

2018 US Device Approvals: The Year Of De Novos And Digital Health
Global Approvals Analysis: Emerging Markets Drive Volume Of OUS Approvals
M&A Analysis: M&A Rises In 2017 As Market Set To Bounce Back In 2018
A No-Predicate 510(k) Future? Pending US FDA Policy Might Forge A Path
A New York Minute: US FDA Leverages State's Health Department To Expedite NGS Reviews
US FDA Implements 'Firm-Based' Regulatory Approach To DTC Genetic Health Risk Tests
Opioid Use Disorder App Marks A Path For 510(k) 'Breakthrough' Devices
Podcast: Thermo Fisher Talks Regulatory Experience With Oncomine
Infographic: 2016 Medical Device Approvals
FDA Hits User-Fee-Era Record For 'Novel' Devices: A New Normal?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT122032

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel